The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.

M. Lafeber; W. Spiering; Y. van der Graaf; H.M. Nathoe; M.L. Bots; D.E. Grobbee; F.L.J. Visseren

doi:10.1016/j.ahj.2013.04.011

The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	282-289
Number of pages	8
Journal	American Heart Journal
Volume	166
Issue number	2
DOIs	https://doi.org/10.1016/j.ahj.2013.04.011
Publication status	Published - 2013

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

10.1016/j.ahj.2013.04.011

http://www.ncbi.nlm.nih.gov/pubmed/23895811

Cite this

Lafeber, M., Spiering, W., van der Graaf, Y., Nathoe, H. M., Bots, M. L., Grobbee, D. E., & Visseren, F. L. J. (2013). The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease. American Heart Journal, 166(2), 282-289. https://doi.org/10.1016/j.ahj.2013.04.011

@article{c7e3f9319be44197a6fe0138839b155a,

title = "The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "M. Lafeber and W. Spiering and \{van der Graaf\}, Y. and H.M. Nathoe and M.L. Bots and D.E. Grobbee and F.L.J. Visseren",

year = "2013",

doi = "10.1016/j.ahj.2013.04.011",

language = "English",

volume = "166",

pages = "282--289",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Elsevier",

number = "2",

}

Lafeber, M, Spiering, W , van der Graaf, Y, Nathoe, HM, Bots, ML , Grobbee, DE & Visseren, FLJ 2013, 'The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.', American Heart Journal, vol. 166, no. 2, pp. 282-289. https://doi.org/10.1016/j.ahj.2013.04.011

The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease. / Lafeber, M.; Spiering, W.; van der Graaf, Y. et al.
In: American Heart Journal, Vol. 166, No. 2, 2013, p. 282-289.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The combined use of aspirin, a statin, in blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease.

AU - Lafeber, M.

AU - Spiering, W.

AU - van der Graaf, Y.

AU - Nathoe, H.M.

AU - Bots, M.L.

AU - Grobbee, D.E.

AU - Visseren, F.L.J.

PY - 2013

Y1 - 2013

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

U2 - 10.1016/j.ahj.2013.04.011

DO - 10.1016/j.ahj.2013.04.011

M3 - Article

C2 - 23895811

SN - 0002-8703

VL - 166

SP - 282

EP - 289

JO - American Heart Journal

JF - American Heart Journal

IS - 2

ER -